Free-breathing MRI for monitoring ventilation changes following antibiotic treatment of pulmonary exacerbations in paediatric cystic fibrosis

Eur Respir J. 2021 Apr 15;57(4):2003104. doi: 10.1183/13993003.03104-2020. Print 2021 Apr.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / drug therapy
  • Humans
  • Lung / diagnostic imaging
  • Magnetic Resonance Imaging
  • Pseudomonas Infections* / drug therapy

Substances

  • Anti-Bacterial Agents

Associated data

  • ClinicalTrials.gov/NCT02740868
  • ClinicalTrials.gov/NCT02606487